Nantahala Capital Management, LLC
Position in UNCY — Unicycive Therapeutics, Inc.
CIK 1472322
New Canaan, CT
Position in UNCY
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$6,572,786
+$392,837 QoQ
Shares Held
1,401,447
+49.2% QoQ
Ownership
5.03%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#2
of 80 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UNCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Nantahala Capital Management, LLC holds $620,287,047 across 52 Biotechnology names. UNCY ranks #32 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SVRA |
Savara Inc
|
6,976,810 | $42,977,149 | |
| 2 | AVTX |
Avalo Therapeutics, Inc.
|
1,862,250 | $34,414,380 | |
| 3 | LBRX |
Lb Pharmaceuticals Inc
|
1,052,894 | $34,171,674 | |
| 4 | ABEO |
Abeona Therapeutics Inc.
|
5,136,490 | $31,743,508 | |
| 5 | ZVRA |
Zevra Therapeutics, Inc.
|
1,797,476 | $25,775,805 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
820,481 | $22,136,577 | |
| 7 | QURE |
uniQure N.V.
|
455,660 | $20,987,699 | |
| 8 | AURA |
Aura Biosciences, Inc.
|
2,951,030 | $20,952,313 |
All Filings in UNCY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,168,722 | 2,807,830 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $6,572,786 | 1,401,447 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $6,179,949 | 939,202 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,419,195 | 939,202 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,094,920 | 939,202 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,479,993 | 939,202 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,400,396 | 9,391,994 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,251,243 | 10,391,994 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,150,706 | 2,820,358 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,412,999 | 2,820,358 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,603,108 | 3,335,586 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,984,341 | 3,438,181 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,984,665 | 3,470,541 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $828,692 | 647,416 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,359,573 | 647,416 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $349,604 | 647,416 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $419,219 | 710,542 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $605,634 | 729,680 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $826,416 | 640,633 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,414,717 | 686,756 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,981,000 | 700,000 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||